JOR Spine · 2021 · 27 citations · 68 references
MedicineOrthopaedic SurgeryOrthopedic SurgeryMusculoskeletal RehabilitationPain ManagementSpine SurgeryDegenerative Spine DiseaseIntervertebral Disc DiseaseLow Back Pain RehabilitationPain-related DisabilitySpinal RehabilitationSpine RehabilitationClinical Evidence ReviewIntervertebral Disc DegenerationIntervertebral Disc PathologyLumbar Degenerative Disc DiseaseLumbar Spine TreatmentSymptomatic Therapy
Low back pain (LBP) is a common clinical problem and a major cause of physical disability, imposing a prominent socioeconomic burden. Intervertebral disc degeneration (IDD) has been considered the main cause of LBP. The current treatments have limited efficacy because they cannot address the underlying degeneration. With an increased understanding of the complex pathological mechanism of IDD, various medications and biological reagents have been used for intradiscal injection for the treatment of LBP. There is increasing clinical evidence showing the benefits of these therapies on symptomatic relief and their potential for disc repair and regeneration by targeting the disrupted pathways underlying the cause of the disease. A brief overview of the potential and limitations for these therapies are provided in this review, based on the recent and available data from clinical trials and systematic reviews. Finally, future perspectives are discussed.
68
Spencer L James, Degu Abate, Kalkidan Hassen Abate et al. · The Lancet · 2018 · 14K citations · Full text
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Jianhui Chang, Yingying Wang, Lijian Shao et al. · Nature Medicine · 2015 · 1.8K citations
Nerve ingrowth into diseased intervertebral disc in chronic back pain
TE Peacock, Philippe Goupille, JA Hoyland et al. · The Lancet · 1997 · 978 citations
Enzyme Dissolution of the Nucleus Pulposus in Humans
Lyman Smith · JAMA · 1964 · 376 citations